![](/images/byd/70.jpg)
![](/images/byd/187.jpg)
![](/images/byd/268.jpg)
![](/images/byd/11.jpg)
![](/images/byd/226.jpg)
![](/images/byd/282.jpg)
(DOC) НББОУС 2 Бараа материал | Od OD
We assessed the efficacy and safety of the combination of the nucleotide polymerase inhibitor sofosbuvir, the NS5A inhibitor velpatasvir, and the NS3/4A protease inhibitor GS-9857 in patients with hepatitis C virus (HCV) genotype 1 infection. We performed an open-label trial at 32 sites in the United States and 2 sites in New Zealand of 197 ...
![](/image/whatsappp.png)
![](/images/byd/113.jpg)
![](/images/byd/236.jpg)
![](/images/byd/325.jpg)
![](/images/byd/69.jpg)
![](/images/byd/227.jpg)
![](/images/byd/341.jpg)
![](/images/byd/31.jpg)
![](/images/byd/159.jpg)
![](/images/byd/270.jpg)
![](/images/byd/66.jpg)
![](/images/byd/238.jpg)
![](/images/byd/307.jpg)
![](/images/byd/8.jpg)
![](/images/byd/228.jpg)
![](/images/byd/241.jpg)
![](/images/byd/77.jpg)
![](/images/byd/180.jpg)
![](/images/byd/331.jpg)
![](/images/byd/102.jpg)
![](/images/byd/173.jpg)
![](/images/byd/291.jpg)
![](/images/byd/36.jpg)
![](/images/byd/170.jpg)
![](/images/byd/330.jpg)
![](/images/byd/51.jpg)
![](/images/byd/131.jpg)
![](/images/byd/264.jpg)
![](/images/byd/14.jpg)
![](/images/byd/167.jpg)
![](/images/byd/267.jpg)
![](/images/byd/65.jpg)
![](/images/byd/173.jpg)
![](/images/byd/295.jpg)
![](/images/byd/103.jpg)
![](/images/byd/204.jpg)
![](/images/byd/252.jpg)
![](/images/byd/55.jpg)
![](/images/byd/169.jpg)
![](/images/byd/251.jpg)
![](/images/byd/66.jpg)
![](/images/byd/232.jpg)
![](/images/byd/360.jpg)
![](/images/byd/63.jpg)
![](/images/byd/233.jpg)
![](/images/byd/358.jpg)
![](/images/byd/115.jpg)
![](/images/byd/212.jpg)
![](/images/byd/243.jpg)
![](/images/byd/38.jpg)
![](/images/byd/219.jpg)
![](/images/byd/354.jpg)
![](/images/byd/71.jpg)
![](/images/byd/155.jpg)
![](/images/byd/310.jpg)
![](/images/byd/9.jpg)
![](/images/byd/204.jpg)
![](/images/byd/349.jpg)
![](/images/byd/28.jpg)
![](/images/byd/215.jpg)
![](/images/byd/251.jpg)
![](/images/byd/48.jpg)
![](/images/byd/217.jpg)
![](/images/byd/243.jpg)
![](/images/byd/12.jpg)
![](/images/byd/156.jpg)
![](/images/byd/251.jpg)
![](/images/byd/32.jpg)
![](/images/byd/129.jpg)
![](/images/byd/279.jpg)
![](/images/byd/101.jpg)
![](/images/byd/193.jpg)
![](/images/byd/268.jpg)
![](/images/byd/7.jpg)
![](/images/byd/239.jpg)
![](/images/byd/288.jpg)
![](/images/byd/111.jpg)
![](/images/byd/194.jpg)
![](/images/byd/286.jpg)
![](/images/byd/111.jpg)
![](/images/byd/229.jpg)
![](/images/byd/350.jpg)
![](/images/byd/1.jpg)
![](/images/byd/201.jpg)
![](/images/byd/292.jpg)
![](/images/byd/87.jpg)
![](/images/byd/206.jpg)
![](/images/byd/285.jpg)
![](/images/byd/7.jpg)
![](/images/byd/167.jpg)
![](/images/byd/313.jpg)
![](/images/byd/120.jpg)
![](/images/byd/163.jpg)
![](/images/byd/303.jpg)
![](/images/byd/4.jpg)
![](/images/byd/121.jpg)
![](/images/byd/325.jpg)
![](/images/byd/90.jpg)
![](/images/byd/151.jpg)
![](/images/byd/294.jpg)